Filipino Multicomponent Intervention to Maintain Cognitive Performance in High Risk Population (FINOMAIN)
FINOMAIN
2 other identifiers
interventional
72
1 country
1
Brief Summary
FINOMAIN is a community-based, cluster randomized controlled trial (cRCT) of dance intervention INDAK and standardized vascular care. The study aims to develop and assess the effectiveness of a cost-effective and culturally - fit intervention for Filipino older adults at high risk for developing dementia. The first objective of the study is to evaluate the efficacy of dance intervention INDAK on cognitive function as assessed by the Alzheimer's Disease Assessment Scale - Cognitive (ADAS-Cog), Mnemonic Similarity Task (MST), and Executive Function Composite (EFC) among older adults with mild cognitive impairment (MCI). To increase the sensitivity of primary outcome for various composites of cognition, aside from ADAS-Cog that assesses core cognitive deficits of dementia, investigators will develop an executive function composite that will combine measures of executive control using performance outcomes on tests including Trail Making Test (TMT), Digit Symbol Substitution Test (DSST), Verbal Fluency Test (VFT), and Number Cancellation Task (NCT). Executive function composite scores have been used to track aging populations at risk for dementia and are shown to be sensitive in capturing cerebrovascular benefits and used as instruments in studies with similar non-pharmacological intervention (i.e. aerobic exercise, dance). Additionally, the investigators will add MST which is a measure for episodic memory, memory representations and pattern discrimination which are all cognitive domains highly correlated with hippocampal function. The second objective of the study is to determine the effect of dance on neuroplasticity as measured by brain volumetry and functional connectivity demonstrated through Magnetic Resonance Imaging (MRI) and change in other behavioral and functional outcomes of participants with MCI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 28, 2019
CompletedFirst Submitted
Initial submission to the registry
February 13, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedOctober 27, 2022
October 1, 2022
1.6 years
February 13, 2020
October 26, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from baseline in Alzheimer's Disease Assessment Scale - Cognitive Score
To measure the cognitive function in Alzheimer's disease (AD), hence its popularity for use in cognitive testing of the effects of AD treatment in clinical trials. It consists of 11 tasks measuring the core cognitive deficits of AD, such as disturbances of memory, language, praxis, attention, visuospatial function and other cognitive abilities. ADAS-Cog was validated for use in the Filipino elderly with age and education stratified norms. Score ranges from 0 to 70 points, with lower scores indicating better cognitive functions.
At 6th month and 12th month of intervention
Change from baseline in Mnemonic Similarity Task score
This task place strong demands on pattern separation, memory representation and measures cognitive domains highly correlated with hippocampal function. Pre-MST use set 1, self-paced timing, consisting two phases: encoding and test part. The encoding phase presents 128 colored photographs of objects on computer screen (2 secs duration; ≥ 0.5 secs inter-stimulus-interval/ISI) to be classified by participants as either indoor (key "V") or outdoor (key "N"). The test phase consists of 192 items (64 repeated items, 64 lure items and 64 foil items; presented 2 secs, ≥ 0.5 secs ISI), in which participants engaged in a modified recognition task identifying each item as Old (key "V"), Similar (key "B") or New (key "N"). Percentage accuracy is calculated, with higher percentage indicating better functions.
At 6th month and 12th month of intervention
Change from baseline in Executive Function Composite score
To evaluate fluency, attention, visual scanning, processing and psychomotor speed.
At 6th month and 12th month of intervention
Secondary Outcomes (4)
Change from baseline in Magnetic Resonance Imaging (MRI)
At 12th month of intervention
Change from baseline in Brief Geriatric Depression Scale (GDS) score
At 6th month and 12th month of intervention
Change from baseline in Change in EuroQoL - Visual Analog Scale (EQVAS) rating
At 6th month and 12th month of intervention
Change from baseline in Change in Berg Balance Scale (BBS) score
At 6th month and 12th month of intervention
Other Outcomes (1)
Compliance
At 6th and 12th month of intervention
Study Arms (2)
INDAK & Standardized Vascular Care Group
EXPERIMENTALThe experimental arm will receive training on the ballroom dance modules called INDAK (Improving Neurocognition through Dance and Kinesthetics), nutrition counseling and vascular risk management
Standardized Vascular Care Group
ACTIVE COMPARATORThe control group will receive nutrition counseling and vascular risk management
Interventions
INDAK (Improving Neurocognition through DAnce and Kinesthetics) is a structured modular dance consisting of 8 types of ballroom dances (Reggae, Cha-cha, Samba, Merengue, Bachata, Swing, Tango and Salsa) with increasing complexity. The intervention group will receive dance intervention from a dance teacher two times a week, one hour each time, for 12 months. Each 60-minute session has 3 parts: 10 minutes warm-up/ stretching, 40 minutes dance proper and 10 minutes cool down. This dance intervention will last for 12 months.
The dietary advice will follow Filipino Nutrition Research Institute (FNRI) recommendation called Pinggang Pinoy or Filipino Plate, which is a picture of a nine-inch plate with foods proportionally distributed among the food groups to provide approximately 1,200 to 1,500 calories per day. It is advised that half of the plate is composed of green leafy vegetables and one serving of fruit per meal. For fruits, 4 to 6 servings are encouraged per day. In general, affordable nutritious food is recommended: high consumption of local fruits and vegetables, brown/purple rice instead of white rice, coconut oil and other vegetable oils, and fish. Participants will be asked to use structured 3-day meal diary for diet monitoring. Individual counseling sessions depending on identified vascular risks based on FNRI recommendations will also be conducted. This is followed-up by study nutritionists every 3-month of intervention period.
The management advice for hypertension, diabetes, and dyslipidemia will be based on Filipino standard clinical practice guidelines. This is followed-up by study physicians every 3-month of intervention period
Eligibility Criteria
You may qualify if:
- Aged ≥ 60 years old
- Mild cognitive impairment (MCI) based on Petersen criteria
- Standardized cognitive test ≥1.5 standard deviation (SD) below norms
- Do not fulfill DSM-V criteria for major cognitive disorders
- Clinical Dementia Rating (CDR) of 0.5
You may not qualify if:
- Significant functional impairment based on Lawton's IADL
- Significant neuropsychiatric impairment based on NPI-Q
- Significant hearing and visual impairment that limit testing and dance participation
- Pre-existing illness that in the judgment of the study physician precludes engagement in moderate physical activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Luke's Medical Center, Philippineslead
- Nanyang Technological Universitycollaborator
- Icahn School of Medicine at Mount Sinaicollaborator
- University of Copenhagencollaborator
Study Sites (1)
Institute for Neurosciences, St. Luke's Medical Center
Quezon City, National Capital Region, 1102, Philippines
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacqueline C Dominguez, MD
St. Luke's Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head, Memory Center
Study Record Dates
First Submitted
February 13, 2020
First Posted
March 10, 2020
Study Start
May 28, 2019
Primary Completion
December 30, 2020
Study Completion
December 30, 2020
Last Updated
October 27, 2022
Record last verified: 2022-10